Total Payments
$182,293
2023 Payments
$17,634
Companies
12
Transactions
253
Payment Breakdown by Category
Consulting$121,592 (66.7%)
Travel$29,283 (16.1%)
Other$24,227 (13.3%)
Food & Beverage$7,103 (3.9%)
Gifts$89.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $121,592 | 35 | 66.7% |
| Travel and Lodging | $29,283 | 110 | 16.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $17,234 | 10 | 9.5% |
| Food and Beverage | $7,103 | 94 | 3.9% |
| Honoraria | $6,993 | 2 | 3.8% |
| Gift | $89.00 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $42,276 | 56 | $0 (2021) |
| EISAI INC. | $33,937 | 66 | $0 (2022) |
| Supernus Pharmaceuticals, Inc. | $16,884 | 19 | $0 (2022) |
| AbbVie Inc. | $15,774 | 18 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $13,553 | 24 | $0 (2020) |
| H. Lundbeck A S | $12,475 | 8 | $0 (2017) |
| Shire North American Group Inc | $11,500 | 15 | $0 (2019) |
| Biogen, Inc. | $10,324 | 4 | $0 (2023) |
| ACADIA Pharmaceuticals Inc | $10,145 | 11 | $0 (2019) |
| Allergan, Inc. | $6,814 | 19 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $17,634 | 8 | Biogen, Inc. ($10,324) |
| 2022 | $21,718 | 29 | EISAI INC. ($8,153) |
| 2021 | $11,906 | 8 | Supernus Pharmaceuticals, Inc. ($6,696) |
| 2020 | $4,049 | 4 | Allergan, Inc. ($2,178) |
| 2019 | $53,269 | 113 | Eisai Inc. ($23,175) |
| 2018 | $21,516 | 24 | Alkermes, Inc. ($10,752) |
| 2017 | $52,199 | 67 | Alkermes, Inc. ($30,274) |
All Payment Transactions
253 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/15/2023 | Biogen, Inc. | Zurzuvae (Drug) | Consulting Fee | Cash or cash equivalent | $2,552.00 | General |
| Category: Neurology | ||||||
| 12/11/2023 | Biogen, Inc. | Zurzuvae (Drug) | Consulting Fee | Cash or cash equivalent | $1,392.00 | General |
| Category: Neurology | ||||||
| 05/22/2023 | Biogen, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,248.00 | General |
| 05/05/2023 | AbbVie Inc. | VRAYLAR (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/04/2023 | AbbVie Inc. | VRAYLAR (Drug) | Consulting Fee | Cash or cash equivalent | $4,500.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/04/2023 | AbbVie Inc. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $175.88 | General |
| Category: NEUROSCIENCE | ||||||
| 05/04/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $133.72 | General |
| Category: NEUROSCIENCE | ||||||
| 01/03/2023 | Biogen, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,132.00 | General |
| 10/13/2022 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $408.21 | General |
| Category: NEUROSCIENCE | ||||||
| 10/12/2022 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $352.82 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $80.82 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2022 | ABBVIE INC. | VRAYLAR (Drug) | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2022 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $84.31 | General |
| Category: NEUROSCIENCE | ||||||
| 07/08/2022 | EISAI INC. | Dayvigo (Drug) | Consulting Fee | Cash or cash equivalent | $6,960.00 | General |
| Category: Neurology | ||||||
| 06/03/2022 | EISAI INC. | Dayvigo (Drug) | Travel and Lodging | Cash or cash equivalent | $710.70 | General |
| Category: Neurology | ||||||
| 06/03/2022 | EISAI INC. | Dayvigo (Drug) | Travel and Lodging | Cash or cash equivalent | $263.93 | General |
| Category: Neurology | ||||||
| 06/03/2022 | EISAI INC. | Dayvigo (Drug) | Travel and Lodging | Cash or cash equivalent | $77.80 | General |
| Category: Neurology | ||||||
| 06/03/2022 | EISAI INC. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $48.71 | General |
| Category: Neurology | ||||||
| 06/03/2022 | EISAI INC. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $48.71 | General |
| Category: Neurology | ||||||
| 06/03/2022 | EISAI INC. | Dayvigo (Drug) | Travel and Lodging | Cash or cash equivalent | $27.70 | General |
| Category: Neurology | ||||||
| 06/03/2022 | EISAI INC. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $12.18 | General |
| Category: Neurology | ||||||
| 06/03/2022 | EISAI INC. | Dayvigo (Drug) | Travel and Lodging | Cash or cash equivalent | $3.00 | General |
| Category: Neurology | ||||||
| 05/12/2022 | Sunovion Pharmaceuticals Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $800.00 | General |
| 04/29/2022 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $502.64 | General |
| Category: NEUROSCIENCE | ||||||
About Dr. Larry Culpepper, M.D
Dr. Larry Culpepper, M.D is a Family Medicine healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225001076.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Larry Culpepper, M.D has received a total of $182,293 in payments from pharmaceutical and medical device companies, with $17,634 received in 2023. These payments were reported across 253 transactions from 12 companies. The most common payment nature is "Consulting Fee" ($121,592).
Ad
Practice Information
- Specialty Family Medicine
- Location Boston, MA
- Active Since 02/10/2006
- Last Updated 11/16/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1225001076
Products in Payments
- VRAYLAR (Drug) $17,052
- TRINTELLIX (Drug) $12,475
- NUPLAZID (Drug) $10,145
- Dayvigo (Drug) $8,153
- MYDAYIS (Drug) $6,372
- QELBREE (Drug) $5,651
- Zurzuvae (Drug) $3,944
- LATUDA (Drug) $2,755
- Aristada 441 mg (Drug) $125.00
- Vivitrol 380 mg (Drug) $42.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Boston
Wilfredo Giordano-Perez, M.d, M.D
Family Medicine — Payments: $277,141
Family Medicine $277,141
Suzanne Mitchell, Md, MD
Family Medicine — Payments: $133,550
Family Medicine $133,550
Dr. Michael Lowney, D.o, D.O
Family Medicine — Payments: $16,927
Family Medicine $16,927
Steven Zivich, Md, MD
Family Medicine — Payments: $8,665
Family Medicine $8,665
Dr. Renee Crichlow, Md, MD
Family Medicine — Payments: $5,476
Family Medicine $5,476
Michael Lowney, D.o, D.O
Family Medicine — Payments: $4,718
Family Medicine $4,718